minutes-o.gif (1287 bytes)

Minutes of
Transbehavioral Outcomes Assessment Workgroup

Pre-Meeting Workshop
July 17, 2002, Washington, DC

Present:

Ron Abeles, OBSSR
John Allegrante, Cornell University
Terry Bazzarre, Robert Wood Johnson Foundation
Susan Czajkowski, NICHD
David Dzewaltowski, Kansas State University
Paul Estabrooks, Kansas State University
Larry Fine, OBSSR
Russ Glasgow, Oregon Research Institute
Trish Jordan, University of Rhode Island
Abby King, Stanford University
Lisa Klesges, University of Tennessee
Jeannine Mjoseth, NIA
Claudio Nigg, University of Rhode Island
Marcia Ory, National Institutes of Health/NIH
Karen Peterson, Harvard School of Public Health
Barb Resnick, University of Maryland
Deborah Toobert, Oregon Research Institute
Geof Williams, University of Rochester
 
Outside Consultants:
Steve Belle, University of Pittsburgh
Peter Briss, Centers for Disease Control and Prevention
Bob Kaplan , University of California, San Diego
Helena Kraemer, Stanford University
 

    
1. Position Paper Presentation (Claudio Nigg)
  • Several approaches to conceptualizing multiple behavior outcomes were presented. The various approaches fell into three categories: a) behavioral outcomes; b) public health outcomes; and c) clinical outcomes.
2. Reaction from Consultants
  • All of the outside consultants agreed that thinking about the TBOA was a very worthwhile exercise. No one in the meeting rejected the idea of trying to accomplish this task.
  • It was agreed, however, that we were not ready to "take our show in the road." There are still many conceptual issues that need to be resolved, and we do not yet have agreement on an outcome criteria for two of our behaviors (physical activity and diet).
  • Helena Kraemer suggested at least one other type of analysis (rank ordering) that may provide reasonable results without having to go the route of a meta-anlysis.

Action Steps: The workgroup will revisit the position paper and decide what our future steps to take. Serious discussion needs to address our target audience. It is likely that different approaches will be useful to different people (e.g., clinicians, researchers, policymakers, etc.).

3. Recommendations
  • Ensure that we retain the opportunity to pursue a TBOA down the road; we have behavioral data.
  • If nothing else, we should use this to prompt a great discussion that the field of behavior medicine should be having. We may be ahead of our time.
  • Recommend to the BCC sites to report standardized effect sizes, cost-benefit and other assessments that will allow future research to include our findings in any meta-analyses or transbehavior analyses that may come about.